Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons ( Papio sp.)
Highlights ► Developed a new experimental model of E. histolytica infection in baboons. ► E. histolytica infection and inflammatory colitis was sustained for 90 days. ► A Gal-lectin-based intranasal synthetic peptide vaccine was efficacious. ► Vaccine efficacy was validated by fecal PCR, colonoscopy...
Saved in:
Published in | Vaccine Vol. 30; no. 20; pp. 3068 - 3075 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
26.04.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Highlights ► Developed a new experimental model of E. histolytica infection in baboons. ► E. histolytica infection and inflammatory colitis was sustained for 90 days. ► A Gal-lectin-based intranasal synthetic peptide vaccine was efficacious. ► Vaccine efficacy was validated by fecal PCR, colonoscopy and pathology. ► Immunity correlated with the ELISA OD value for intestinal anti-lectin IgA. |
---|---|
Bibliography: | http://dx.doi.org/10.1016/j.vaccine.2012.02.066 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2012.02.066 |